Our claim
With the uniqueness and limitless possibilities of the EDIM process developed by us, it is our incentive as well as our obligation to carry on research on this path and to develop diagnostics with competent partners, which allows all patients a targeted therapy at an early stage.
Our company history
Our company history simply and clearly summarized for you.
1995
Discovery of TKTL1
Dr. Johannes Coy Discovers new universal biomarker at the German Institute for Cancer Research2007
Foundation of Zyagnum AG
Zyagnum is founded to develop a technology platform and diagnostic test for cancer2010
First in-house test
The first cancer-in-house test based on TKTL1 is launched in Germany - testing accuracy is not reliable and high enough for a commercial screening test2017
Development completed
Zyagnum finishes development of the unique EDIM technology and achieves registration of the PanTum Detect cancer screening test2018
PanTum Detect
Global market launch & development of additional tests.Our partners
You want to work with us?
Would you like to work in a company where you can influence the future of mankind in a sustainable way? Your goal is to make the world a more beautiful and safer place? Our personnel experts are looking forward to your application.
OUR JOBS